bpc-157 fda warning august 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The Hidden Risks of BPC‑157:
Description
For this reason, it is often cited as one of the most interesting regenerative peptides
Mild side effects can include short-term injection-site redness and very rarely transient mild headache in the first week
Until more is known, high-dose cyanocobalamin should generally not be recommended for people with kidney disease
This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care
